News summary

Engineered human Argonaute 2 for targeted C-to-U RNA base editing

Source: Nature - Biotechnology • Published: 20 Oct 2026, 00:00

Summarized by Masters of Longevity from Nature - Biotechnology.

Engineered human Argonaute 2 is presented as a programmable RNA-targeting platform; this article explains the approach, guide design, and platform potential.

Engineered human Argonaute 2 for targeted C-to-U RNA base editing
Key Takeaways
  • Human Argonaute 2 (AGO2) can be repurposed as a programmable RNA-targeting platform when fused to a C-to-U deaminase.
  • ALTER uses redesigned guide RNAs that remodel local target RNA structure to enable selective C-to-U editing with reduced nuclease activity.
  • In HEK293T cells, ALTER produced higher on-target C-to-U editing and comparable or lower transcriptome-wide off-target editing than Cas13-based editors.
Read the full article at Nature - Biotechnology ↗

Continue exploring

Recommended MoL Picks

MoL PickReducing Inflammation from Ageing Cells: What a Mouse Study FoundResearchers reduced the inflammatory signals released by cells that had stopped dividing. Older mice also improved on some strength and frailty tests. Whether this approach could help people remains unknown.MoL PickWhat Changes in the Human Hippocampus with Age?A study of 40 postmortem brains maps a midlife shift in immune cells and a wider loss of cellular and genome organisation—but it does not show how to prevent cognitive decline.MoL PickNucleotides and Longevity: Is the Evidence Ready?They help build DNA and keep cells working. Early human studies make nucleotide supplements interesting—but leave important questions about healthy ageing unanswered. Yet.